↓ Skip to main content

Effects of combined MAO-B inhibitors and levodopa vs. monotherapy in Parkinson’s disease

Overview of attention for article published in Frontiers in Aging Neuroscience, July 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
2 X users

Citations

dimensions_citation
34 Dimensions

Readers on

mendeley
126 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Effects of combined MAO-B inhibitors and levodopa vs. monotherapy in Parkinson’s disease
Published in
Frontiers in Aging Neuroscience, July 2014
DOI 10.3389/fnagi.2014.00180
Pubmed ID
Authors

Rakhee Krishna, Manal Ali, Ahmed A. Moustafa

Abstract

Prior studies report that monoamine oxidases inhibitors (MAO-I) when used as an adjunct to levodopa ameliorate motor symptoms in Parkinson's disease (PD), but this was not tested in relation to cognitive or psychiatric measures.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 126 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Canada 1 <1%
Unknown 124 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 26 21%
Student > Ph. D. Student 22 17%
Student > Master 12 10%
Researcher 9 7%
Student > Doctoral Student 7 6%
Other 20 16%
Unknown 30 24%
Readers by discipline Count As %
Psychology 26 21%
Medicine and Dentistry 21 17%
Neuroscience 12 10%
Pharmacology, Toxicology and Pharmaceutical Science 8 6%
Biochemistry, Genetics and Molecular Biology 6 5%
Other 17 13%
Unknown 36 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 July 2014.
All research outputs
#15,690,772
of 23,316,003 outputs
Outputs from Frontiers in Aging Neuroscience
#3,707
of 4,944 outputs
Outputs of similar age
#134,052
of 230,072 outputs
Outputs of similar age from Frontiers in Aging Neuroscience
#53
of 80 outputs
Altmetric has tracked 23,316,003 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,944 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.2. This one is in the 20th percentile – i.e., 20% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 230,072 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 32nd percentile – i.e., 32% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 80 others from the same source and published within six weeks on either side of this one. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.